Simona Francese

The sample preparation for us takes about a couple of hours, but the results can be obtained in minutes.

Then we trained a machine learning algorithm to recognize the protein patterns coming from women with early breast cancer

benign and metastatic, OK?

And we found out that we can tell them apart with the 97.8 percent of accuracy against the 70 to 90 percent accuracy of a mammogram.

And the results are shown in this confusion matrix.

I don't know why it's called confusion, but it's the confusion matrix.

What it tells you there is that of 135 samples, we spotted every time a woman had cancer.

So, do you think

that a test that will reduce the NHS costs, that bypasses the backlogs, that doesn't require any more resources, that is non-invasive, that is painless, radiation-free, that increases accessibility because in our vision,

We can take this test at the GP practices, even in the comfort of your own home, and then we can ship it COVID-style, as we used to do.

So it really solves the accessibility problem as well.

And in doing all this, it obviously increases compliance, and hence, it saves lives.

And do you think that something like this is not worth the investment, the dedication, the perseverance?

I think it is.

And I think that this is definitely an idea worth sharing.